133 related articles for article (PubMed ID: 10942975)
1. [IGM hyperimmunoglobulinemia anti-phosphatidylethanolamine antibodies of the IgM isotype: clinical and biological study of 72 patients with immune disorders].
Granel B; Serratrice J; Hubert AM; Volot F; Pache X; Swiader L; Rossi P; Disdier P; Weiller PJ
Rev Med Interne; 2000 Jul; 21(7):595-8. PubMed ID: 10942975
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
[TBL] [Abstract][Full Text] [Related]
3. The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.
Hou S; Harper PE; Bardin N; Zhao M
J Immunol Methods; 2017 Jan; 440():27-34. PubMed ID: 27784626
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses.
Sanmarco M; Alessi MC; Harle JR; Sapin C; Aillaud MF; Gentile S; Juhan-Vague I; Weiller PJ
Thromb Haemost; 2001 May; 85(5):800-5. PubMed ID: 11372671
[TBL] [Abstract][Full Text] [Related]
5. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
Sanmarco M; Boffa MC
Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
[TBL] [Abstract][Full Text] [Related]
6. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE).
Bertolaccini ML; Murru V; Sciascia S; Sanna G; Khamashta MA
Thromb Res; 2012 Dec; 130(6):914-8. PubMed ID: 23079292
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
Sugi T; McIntyre JA
Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
[TBL] [Abstract][Full Text] [Related]
8. ELISA for antiphosphatidylethanolamine antibody detection: high impact of assay buffer on results.
Sanmarco M
J Immunol Methods; 2010 Jun; 358(1-2):9-16. PubMed ID: 20382150
[TBL] [Abstract][Full Text] [Related]
9. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases.
Berard M; Chantome R; Marcelli A; Boffa MC
J Rheumatol; 1996 Aug; 23(8):1369-74. PubMed ID: 8856615
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
11. The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome.
Bećarević M; Stojanović L; Ignjatović S; Dopsaj V
Clin Rheumatol; 2016 May; 35(5):1361-5. PubMed ID: 26971791
[TBL] [Abstract][Full Text] [Related]
12. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.
Boffa MC; Berard M; Sugi T; McIntyre JA
J Rheumatol; 1996 Aug; 23(8):1375-9. PubMed ID: 8856616
[TBL] [Abstract][Full Text] [Related]
13. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
Hirmerova J; Ulcova-Gallova Z; Seidlerova J; Filipovsky J; Bibkova K; Micanova Z; Mayer O
Clin Appl Thromb Hemost; 2010 Jun; 16(3):318-25. PubMed ID: 19221100
[TBL] [Abstract][Full Text] [Related]
14. [Which place of antiphosphatidylethanolamine antibodies research in seronegative antiphospholipid syndrome suspicion?].
Billoir P; Miranda S; Abboud J; Armengol G; Levesque H; Benhamou Y; Le Cam Duchez V
Rev Med Interne; 2019 Jun; 40(6):351-354. PubMed ID: 30905593
[TBL] [Abstract][Full Text] [Related]
15. Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss.
Sugi T; Matsubayashi H; Inomo A; Dan L; Makino T
J Obstet Gynaecol Res; 2004 Aug; 30(4):326-32. PubMed ID: 15238112
[TBL] [Abstract][Full Text] [Related]
16. Significance of Anti-Phosphatidylethanolamine Antibodies in the Pathogenesis of Recurrent Pregnancy Loss.
Yonezawa M; Kuwabara Y; Ono S; Ouchi N; Ichikawa T; Takeshita T
Reprod Sci; 2020 Oct; 27(10):1888-1893. PubMed ID: 32548803
[TBL] [Abstract][Full Text] [Related]
17. Antiphosphatidylethanolamine antibodies might not be an independent risk factor for further miscarriage in patients suffering recurrent pregnancy loss.
Obayashi S; Ozaki Y; Sugi T; Kitaori T; Katano K; Suzuki S; Sugiura-Ogasawara M
J Reprod Immunol; 2010 Jun; 85(2):186-92. PubMed ID: 20462639
[TBL] [Abstract][Full Text] [Related]
18. The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome.
Bećarević M
J Thromb Thrombolysis; 2016 Nov; 42(4):552-7. PubMed ID: 27307251
[TBL] [Abstract][Full Text] [Related]
19. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
20. Can cryoglobulins interfere with the measurement of IgM antiphosphatidylethanolamine antibodies by ELISA?
Bardin N; Pommier G; Sanmarco M
Thromb Res; 2007; 119(4):441-6. PubMed ID: 16766022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
